Mycobacterial disease in patients with rheumatic disease

@article{Ingen2008MycobacterialDI,
  title={Mycobacterial disease in patients with rheumatic disease},
  author={Jakko van Ingen and Martin J. Boeree and P N Richard Dekhuijzen and Dick van Soolingen},
  journal={Nature Clinical Practice Rheumatology},
  year={2008},
  volume={4},
  pages={649-656}
}
This Review focuses on the emergence of mycobacterial disease in patients undergoing treatment for rheumatic disease with four new drug classes—tumor necrosis factor (TNF) inhibitors, human interleukin (IL)-1 receptor antagonists, anti-CD20 antibodies and CD4+ T-cell costimulation modulators—collectively referred to as biologic agents. Mycobacterial disease is a major cause of severe infection in patients undergoing anti-TNF therapy. Reports are now emerging of an association between… CONTINUE READING
17 Extracted Citations
56 Extracted References
Similar Papers

Citing Papers

Publications influenced by this paper.
Showing 1-10 of 17 extracted citations

Referenced Papers

Publications referenced by this paper.
Showing 1-10 of 56 references

Altered expression of isoniazid-regulated genes in drug-treated dormant Mycobacterium tuberculosis

  • PC Karakousis
  • J Antimicrob Chemother
  • 2008

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis

  • KG Saag
  • Arthritis Rheum
  • 2008

Clinical relevance of Mycobacterium szulgai in the Netherlands

  • J van Ingen
  • Clin Infect Dis
  • 2008

Clinical relevance of Mycobacterium xenopi isolation and its determinants in the Netherlands

  • J vanIngen
  • Emerg Infect Dis
  • 2008

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebocontrolled, randomised trial

  • JS Smolen
  • Lancet
  • 2008

Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis

  • AB Gottlieb
  • Rheumatology ( Oxford )
  • 2008

Efficacy of infliximab

  • M Naganuma
  • 2008

Similar Papers

Loading similar papers…